Marta Vorland
Overview
Explore the profile of Marta Vorland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lilleskare S, Vorland M, Vo A, Aarsand A, Reikvam H
Scand J Clin Lab Invest
. 2022 Dec;
83(1):3-7.
PMID: 36476017
Myeloproliferative neoplasms are hematological disorders characterized by increased production in one or more myeloid cell lines, associated with driver mutations in and genes. The aims of this study were to...
2.
Sandnes M, Vorland M, Ulvik R, Reikvam H
Genes (Basel)
. 2021 Aug;
12(8).
PMID: 34440336
hemochromatosis is characterized by increased iron absorption and iron overload due to variants of the iron-regulating gene. Overt disease is mainly associated with homozygosity for the C282Y variant, although the...
3.
Sandnes M, Ulvik R, Vorland M, Reikvam H
J Clin Med
. 2021 Jun;
10(9).
PMID: 34067164
Ferritin is one of the most frequently requested laboratory tests in primary and secondary care, and levels often deviate from reference ranges. Serving as an indirect marker for total body...
4.
Bustad H, Kallio J, Vorland M, Fiorentino V, Sandberg S, Schmitt C, et al.
Int J Mol Sci
. 2021 Jan;
22(2).
PMID: 33445488
Acute intermittent porphyria (AIP) is an autosomal dominant inherited disease with low clinical penetrance, caused by mutations in the hydroxymethylbilane synthase () gene, which encodes the third enzyme in the...
5.
Bustad H, Toska K, Schmitt C, Vorland M, Skjaerven L, Kallio J, et al.
Mol Ther
. 2019 Dec;
28(2):677-689.
PMID: 31810863
Mutations in hydroxymethylbilane synthase (HMBS) cause acute intermittent porphyria (AIP), an autosomal dominant disease where typically only one HMBS allele is mutated. In AIP, the accumulation of porphyrin precursors triggers...
6.
Asp J, Skov V, Bellosillo B, Kristensen T, Lippert E, Dicker F, et al.
Ann Hematol
. 2018 Dec;
98(5):1111-1118.
PMID: 30535576
External quality assurance (EQA) programs are vital to ensure high quality and standardized results in molecular diagnostics. It is important that EQA for quantitative analysis takes into account the variation...
7.
Brattas M, Lilleeng K, Hovland R, Laegreid I, Vorland M, Leh F, et al.
Biomark Res
. 2018 Nov;
6:33.
PMID: 30479769
Background: A feature of myeloproliferative neoplasia is transforming to more aggressive and malignant myeloid neoplasia, including acute myeloid leukemia. Different pathogenesis mechanisms participate in transformation, including transformation of existing potential...
8.
Almedal H, Vorland M, Aarsand A, Gronningsaeter I, Bruserud O, Reikvam H
Tidsskr Nor Laegeforen
. 2016 Dec;
136(22):1889-1894.
PMID: 27929554
Background: The relationship between the JAK2V617F mutation and myeloproliferative neoplasms was described in 2005, and has since paved the way for a new understanding of these diseases. The purpose of...
9.
Bustad H, Vorland M, Ronneseth E, Sandberg S, Martinez A, Toska K
Biosci Rep
. 2013 Jul;
33(4).
PMID: 23815679
The autosomal dominantly inherited disease AIP (acute intermittent porphyria) is caused by mutations in HMBS [hydroxymethylbilane synthase; also known as PBG (porphobilinogen) deaminase], the third enzyme in the haem biosynthesis...
10.
Thorsen V, Vorland M, Bjorndal B, Bruland O, Holmsen H, Lillehaug J
Biochim Biophys Acta
. 2003 Jun;
1632(1-3):62-71.
PMID: 12782152
We have studied phospholipase D (PLD) activation in relation to protein kinase C (PKC) and the involvement of PLD in extracellularly regulated kinase 1 (MAPK) (ERK1) activation and c-fos mRNA...